We are excited to announce the launch of a new partnership between MIMS Australia and the Australian Dental Association (ADA) commencing in 2026.
Through this new partnership, MIMS AU will be providing the exclusive benefit for all ADA members to access its tailored medicines resource designed for dental practitioners — MIMS Drugs4dent®.
MIMS Drugs4dent® is a trusted medicines information resource developed in collaboration with the University of Melbourne Dental School, created by dentists for dentists.
The exclusive ADA member benefit will become available in early 2026 — so stay tuned for more updates on how to access this exciting new offer.
Pictured: MIMS AU CEO Robert Best and ADA CEO Dr. Kate More acknowledging this new, official partnership.